CytomX Therapeutics, Inc. (CTMX)
Nasdaq: CTMX · CIK 0001501989 · United States
Every official CytomX Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open CTMX filings
CytomX Therapeutics, Inc. documents
- CytomX Therapeutics, Inc. 10-K 2026CTMX 10-K 2026: annual report for fiscal 2026
- CytomX Therapeutics, Inc. 10-K 2025CTMX 10-K 2025: annual report for fiscal 2025
- CytomX Therapeutics, Inc. 10-K 2024CTMX 10-K 2024: annual report for fiscal 2024
- CytomX Therapeutics, Inc. 10-K 2023CTMX 10-K 2023: annual report for fiscal 2023
- CytomX Therapeutics, Inc. 10-K 2022CTMX 10-K 2022: annual report for fiscal 2022
- CytomX Therapeutics, Inc. 10-Q 2026CTMX 10-Q 2026: quarterly report for fiscal 2026
- CytomX Therapeutics, Inc. 10-Q 2025CTMX 10-Q 2025: quarterly report for fiscal 2025
- CytomX Therapeutics, Inc. 10-Q 2024CTMX 10-Q 2024: quarterly report for fiscal 2024
- CytomX Therapeutics, Inc. 10-Q 2023CTMX 10-Q 2023: quarterly report for fiscal 2023
- CytomX Therapeutics, Inc. 10-Q 2022CTMX 10-Q 2022: quarterly report for fiscal 2022
- CytomX Therapeutics, Inc. 8-K 2026CTMX 8-K 2026: current report for fiscal 2026
- CytomX Therapeutics, Inc. 8-K 2025CTMX 8-K 2025: current report for fiscal 2025
- CytomX Therapeutics, Inc. 8-K 2024CTMX 8-K 2024: current report for fiscal 2024
- CytomX Therapeutics, Inc. 8-K 2023CTMX 8-K 2023: current report for fiscal 2023
- CytomX Therapeutics, Inc. 8-K 2022CTMX 8-K 2022: current report for fiscal 2022
- CytomX Therapeutics, Inc. DEF 14A 2026CTMX DEF 14A 2026: proxy statement for fiscal 2026
- CytomX Therapeutics, Inc. DEF 14A 2025CTMX DEF 14A 2025: proxy statement for fiscal 2025
- CytomX Therapeutics, Inc. DEF 14A 2024CTMX DEF 14A 2024: proxy statement for fiscal 2024
- CytomX Therapeutics, Inc. DEF 14A 2023CTMX DEF 14A 2023: proxy statement for fiscal 2023
- CytomX Therapeutics, Inc. DEF 14A 2022CTMX DEF 14A 2022: proxy statement for fiscal 2022
- CytomX Therapeutics, Inc. Form 4 2026CTMX Form 4 2026: insider trading filing for fiscal 2026
- CytomX Therapeutics, Inc. Form 4 2025CTMX Form 4 2025: insider trading filing for fiscal 2025
- CytomX Therapeutics, Inc. Form 4 2024CTMX Form 4 2024: insider trading filing for fiscal 2024
- CytomX Therapeutics, Inc. Form 4 2023CTMX Form 4 2023: insider trading filing for fiscal 2023
- CytomX Therapeutics, Inc. Form 4 2022CTMX Form 4 2022: insider trading filing for fiscal 2022
- CytomX Therapeutics, Inc. S-1 2026CTMX S-1 2026: registration statement for fiscal 2026
- CytomX Therapeutics, Inc. S-1 2025CTMX S-1 2025: registration statement for fiscal 2025
- CytomX Therapeutics, Inc. S-1 2024CTMX S-1 2024: registration statement for fiscal 2024
- CytomX Therapeutics, Inc. S-1 2023CTMX S-1 2023: registration statement for fiscal 2023
- CytomX Therapeutics, Inc. S-1 2022CTMX S-1 2022: registration statement for fiscal 2022
- CytomX Therapeutics, Inc. 13F 2026CTMX 13F 2026: institutional holdings for fiscal 2026
- CytomX Therapeutics, Inc. 13F 2025CTMX 13F 2025: institutional holdings for fiscal 2025
- CytomX Therapeutics, Inc. 13F 2024CTMX 13F 2024: institutional holdings for fiscal 2024
- CytomX Therapeutics, Inc. 13F 2023CTMX 13F 2023: institutional holdings for fiscal 2023
- CytomX Therapeutics, Inc. 13F 2022CTMX 13F 2022: institutional holdings for fiscal 2022
More companies